Despite a slower Q2, Needham sees medtech market growing 7% in 2023 (NYSE:BSX)
enot-poloskun Needham sees the medtech sector growing by 7% in 2023 versus 5.7% last year, despite slowed growth in Q2, ...
Tag: NYSEBSX
Recommended.
enot-poloskun Needham sees the medtech sector growing by 7% in 2023 versus 5.7% last year, despite slowed growth in Q2, ...
